ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing
As a
Discrete chemokine or chemoattractant receptors play a specific role in how certain diseases progress. So, each of our drug candidates focuses on a specific chemokine or chemoattractant receptor that blocks the negative inflammatory or suppressive response driven by that particular receptor, while leaving the rest of the immune system intact.
We are passionate about the science underlying the chemoattractant network. More than that, though, we are passionate about the opportunity it holds to provide better medicines for better lives.